UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000008866
Receipt number R000010266
Scientific Title Randomized Phase III Study of mFOLFOX7 or CAPOX plus Bevacizumab versus 5-Fluorouracil/Leucovorin or Capecitabine plus Bevacizumab as First-line Treatment in Elderly Patients with Metastatic Colorectal Cancer (JCOG1018, RESPECT)
Date of disclosure of the study information 2012/09/06
Last modified on 2021/01/05 17:32:04

No. Disposal Last modified on Item of update
1 Insert 2012/09/06 15:25:04
2 Update 2012/09/06 15:29:14 Recruitment status
Anticipated trial start date
3 Update 2014/08/27 12:16:50 Organization
Organization
Division name
Address
Address
TEL
Email
Division name
Division name
Organization1
Institutions
4 Update 2014/08/27 12:17:24 Last follow-up date
5 Update 2016/07/11 14:39:36 Recruitment status
6 Update 2016/11/04 13:10:05 Recruitment status
7 Update 2016/12/08 15:28:19 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
8 Update 2016/12/08 15:33:26 Name of primary person or sponsor
Organization
Organization
Institutions
9 Update 2016/12/08 15:34:05 Last follow-up date
10 Update 2021/01/05 17:32:04 Recruitment status
Date of IRB